Genome editing advances drug discovery in biomedical research.

Ask Alan Frohman how he found out that he had glaucoma, and he'll quickly tell you that there were no warning signs.

Phil Gotwals talks about his vision for the future of business development for research.

Chronic diseases kill 38 million people per year worldwide; almost three-quarters of those deaths occur in low- and middle-income countries. It’s time to act.

Researchers from Seattle Children’s and Novartis shed light on developmental brain disorders that lead to intractable epilepsy.

A diminutive protein prompts a closer look at DNA dark matter.

A new type of medicine that targets RNA was discovered by accident and could change the way some diseases are treated.

Inside the hunt for new antivirals to combat the current pandemic and to prepare for future ones.

Discovery points toward treatment options beyond insulin injections